We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.005 | -0.34% | 1.475 | 1.45 | 1.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1.475 | 1.475 | 1.475 | 636,264 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.28 | 11.4M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 16/4/2024 | 07:00 | UK RNS | Shield Therapeutics PLC Notice of Results |
| 21/2/2024 | 12:36 | ALNC |  Shield Therapeutics sinks as strong performance marred by data issues |
| 21/2/2024 | 07:00 | UK RNS | Shield Therapeutics PLC Unaudited Full Year Trading Update |
| 09/1/2024 | 11:33 | ALNC | IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO |
| 09/1/2024 | 07:00 | UKREG | Shield Therapeutics PLC Appointment of new Chief Financial Officer |
| 07/12/2023 | 15:31 | ALNC | TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract |
| 07/12/2023 | 07:00 | UKREG | Shield Therapeutics PLC Q3 2023 U.S. Commercial Highlights |
| 27/11/2023 | 17:24 | UKREG | Shield Therapeutics PLC PDMR Transaction Notification |
| 20/10/2023 | 11:45 | RNSNON | Shield Therapeutics PLC Abstract to be presented at Healthcare Conference |
| 12/10/2023 | 11:14 | ALNC | IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave |
1 Year Shield Therapeutics Chart |
Intraday Shield Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
